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Abstract
Endometrial hyperplasia is a benign pathology of the uterine mucosa, characterized by certain histological changes,
characterized as simple and complex, non-atypical and atypical forms. Hyperplastic processes of endometrium, according
to various authors, in the structure of gynecological pathology make up 15 to 40%. Clinically, the endometrial hyperplasia
manifest by uterine bleeding. Maternal bleeding that is not susceptible to hormonal, symptomatic, and hemostatic therapy,
leads to chronic post-hemorrhagic anemia and is the indication for surgical intervention. Consequently, systemic disorders of
the hemostasis parameters on the background of uterine bleeding with endometrial hyperplasia, in particular the regulation
of the aggregate state of blood systems, require further research to identify new pathogenetic links and develop correction
methods.
Materials and methods. State of platelet-vascular hemostasis was assessed by the percentage of platelets adhesion in the
blood and by the index of spontaneous platelet aggregation. Total potential coagulation of blood, plasma fibrinolytic activity,
plasminogen potential activity, antiplasmin, fibrinogen in blood plasma, the activity of antithrombin III, the concentration of
soluble fibrin monomer complexes in the blood was determined by reagents made by Simko Ltd company (Ukraine). Using
the ”Thromboelastohraph ACG” machine we identified parameters of thrombin clotting rate, thromboelastograph K constant,
specific platelets convolution constants, α-angle and coagulation composite index.
Results. In women with anemia of III-rd degree against background of the uterine bleeding, at high activity of primary
hemostasis, structural and chronometric hypocoagulation develops; it is predefined by the acute decreasing of fibrinogen
in the blood. The principal reason of hypofibrinogenaemia is the excessive activating of non-fermentative fibrinolysis. In
conclusion, changes in the system of regulation of the aggregate state of blood in women with severe degree of anemia are
the display of subclinical inopexia that develops as a result of thrombocytes high functional activity.
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Problem statement and analysis of the
recent research
Endometrial hyperplasia (EH) - is a benign pathology of the
uterine mucosa, characterized by certain histological changes,
characterized as simple and complex, non-atypical and atypi-
cal forms. Hyperplastic processes of endometrium, according
to various authors, in the structure of gynecological pathology
make up 15 to 40%.Most cases of endometrial hyperplasia re-
sult from high levels of estrogens, combined with insufficient
levels of the progesterone-like hormones which ordinarily
counteract estrogen’s proliferative effects on this tissue. This
may occur in a number of settings, including obesity, polycys-
tic ovary syndrome, hyperinsulinemia etc [2, 4, 6].
Clinically, the endometrial hyperplasia is manifested by
uterine bleeding [5, 7]. The degree of severity of EH de-
termines the intensity and duration of bleeding, anatomical
substrate of this are hyperplastic endometrium, hemorrhages
and necrosis of cells. Maternal bleeding that is not susceptible
to hormonal, symptomatic, and hemostatic therapy, leads to
chronic post-hemorrhagic anemia and is the indication for sur-
gical intervention [1, 3]. Consequently, systemic disorders of
the hemostasis parameters on the background of uterine bleed-
ing with endometrial hyperplasia, in particular the regulation
of the aggregate state of blood system require further research
to identify new pathogenetic links and develop correction
methods.
1. Materials and methods
State of platelet-vascular hemostasis was assessed by the per-
centage of platelets adhesion in the blood and by the index of
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spontaneous platelet aggregation. Total potential coagulation
of blood, plasma fibrinolytic activity, plasminogen potential
activity, antiplasmin, fibrinogen in blood plasma, the activ-
ity of antithrombin III, the concentration of soluble fibrin
monomer complexes in the blood was determined by reagents
made by Simko Ltd company (Ukraine). Using the Trom-
boelastohraph ACG machine we identified parameters of
thrombin clotting rate, tromboelastograph K constant, spe-
cific platelets convolution constants, α-angle and coagulation
composite index.
2. Results
Women with third degree of anemia combined with uter-
ine bleeding revealed a clear chronometric hypocoagulation:
plasma recalcification period was in 1.62 times higher com-
paring with control data; prothrombin ratio was 1.47 times
higher than the control and thrombin clotting time extended
relative to the reference level at 54.14% (Table 1). Inhibi-
tion of thrombogenesis intensity against internal through pro-
thrombin complex formation was confirmed by a significant
increase in activated partial thromboplastin time. The imme-
diate cause of low fibrinogen level in blood plasma in women
with anemia III level against background of uterine bleeding
was the excessive blood plasma fibrinolytic system activation:
total fibrinolytic activity increased by 1.80 times due to a sig-
nificant increase of the non-enzymatic fibrinolysis intensity,
whereas fibrin enzymatic lysis did not differ significantly from
the control data.
We should draw attention on blood changes of women
with a high degree fibrinolysis products of anemia: soluble
fibrin monomer complexes in blood plasma increased by 3.84
times, plasma content of fibrin/fibrinogen degradation prod-
ucts also increased more than 3 times. Otherwise enzymatic
fibrinolysis reserves remained: plasminogen potential activity
corresponded to the control level and intensity of Hageman-
dependent fibrinolysis exceeded the control data.
Women with III anemia degree, suffering from uterine
bleeding of various origins, showed a significant thrombino-
genesis speed decrease. Thromboelastohraph constant k is
almost 2 times higher than the control data. The maximum
amplitude of thromboelasthographic curve decreased signifi-
cantly, indicating a degree of independence between depres-
sion of blood clot density and the functional state of platelets.
It has been estimated that in women with a high degree of
structural anemia hypocoagulation was not accompanied by
platelets activity decrease but conversely specific platelet clot-
ting constant decreased.
3. Conclusions
Therefore, changes in fibrinolytic blood potential in women
with anemia III degree has a secondary character, due to
activation of thrombin- and fibrin-genesis by external way
mechanisms. Chronometric hypercoagulation develops as
a result of blood coagulation activation by external mech-
anism of prothrombinase formation, accompanied by a de-
crease of anticoagulative capacity and a significant increase
in adhesional-aggregational properties of platelets.
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Table 1. The condition of blood coagulation and anticoagulation ability of women with uterine bleeding (x±Sx)
Indicators studied Control data (n=30) Anemia of III-rd degree (n=30)
Recalcification period, sec 82.34±4.61 133.42±7.49p<0.001
Prothrombin time, sec 20.09±0.67 29.55±1.42p<0.001
Thrombin time, sec 11.04±0.75 15.71±0.95p<0.001
Activated partial thromboplastin time, sec 33.83±0.96 46.41±3.19p<0.001
Percentage of adhesive thrombocytes, % 35.44±2.37 71.42±5.18p<0,001
Index of platelet aggregation spontaneous, units 4.08±0.44 10.21±0.65p<0.001
Antithrombin III, % 96.74±3.79 62.51±3.79p<0.001
Activity of the XIII factor, % 101.52±5.26 76.91±3.28p<0.001
Fibrinogen concentration in blood plasma, g/l 3.91±0.31 2.01±0.26p<0.001
Total fibrinolytic activity, E440/ml/h 4.52±0.52 8.26±0,72p<0,001
Non-enzymatic fibrinolysis, E440/ml/h 0.61±0.07 2,92±0.25p<0.001
Enzymatic fibrinolysis, E440/ml/h 4.01±0.47 4.94±0.57p>0.001
Antiplasmines, % 101.70±7.44 129.67±7.98p<0.001
Soluble fibrin monomer complexes, mkg/ml 2.08±0.19 7.99±0.76p<0.001
Fibrin/fibrinogen degradation products, mkg/ml 1.04±0.08 4,05±0,52p<0.001
Plasminogen potential activity, min 15.02±2.10 17.80±2.94p>0.05
Hageman-dependent fibrinolysis, min 15.97±2.96 10.07±1.71p<0.001
Notes:
p - the degree of probability of difference of indicators in comparison with control;
n - is the number of observations.
